ÂÜÀòÂÒÂ×

Gina Wallar is an accomplished executive in the biotechnology and clinical services sectors, currently serving as Chief Business Officer at Biocartis since April 2024. Previously, Wallar held the position of Chief Commercial Officer at Flagship Biosciences, Inc. from March 2023 to April 2024, and served as SVP and General Manager at Fulgent Genetics from June 2022 to March 2023. Wallar's extensive experience includes leadership roles at NeoGenomics Laboratories, where responsibilities encompassed President of Pharma Services and various senior vice president and director positions from September 2014 to June 2022, as well as a directorial role at LabCorp from April 2002 to July 2014. Wallar began a career in epidemiology as an Epidemiologist/Project Manager at The Parkinson's Institute from July 2001 to April 2002. Educational qualifications include a PhD in Molecular Epidemiology from the University of California, Los Angeles (2009-2013), an MPH in Epidemiology and Biostatistics from Boston University (1999-2001), and a BS in Microbiology and Molecular Genetics from UCLA (1992-1996).